Fingerprint
Dive into the research topics of 'Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing
David W. Dodick, Christopher Gottschalk, Roger Cady, Joe Hirman, Jeff Smith, Steve Snapinn
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations